Table 2.
No ACLF | ACLF (all grades) | P value | |
---|---|---|---|
At enrollment (all patients)a | |||
Leukocyte count (×109/L) | 6.8 ± 4.1 | 10.1 ± 0.4 | <0.01 |
C-reactive protein (mg/L) | 25.4 ± 31.9 | 39.4 ± 42.7 | <0.01 |
At enrollment (patients without bacterial infection)b | |||
Leukocyte count (×109/L) | 6.6 ± 3.8 | 9.4 ± 5.3 | <0.01 |
C-reactive protein (mg/L) | 20.9 ± 24.5 | 33.4 ± 38.5 | <0.01 |
After enrollment (all patients)c | |||
Leukocyte count (×109/L) | 5.9 ± 4.0 | 9.3 ± 5.7 | <0.01 |
C-reactive protein (mg/L) | 18.1 ± 17.7 | 36.2 ± 35.9 | <0.01 |
After enrollment (patients without bacterial infection)d | |||
Leukocyte count (×109/L) | 6.0 ± 3.9 | 9.0 ± 5.4 | <0.01 |
C-reactive protein (mg/L) | 16.2 ± 14.6 | 34.4 ± 37.7 | <0.01 |
Leukocyte count and plasma C-reactive protein levels were measured in 1037 and 762 patients without ACLF and in 302 and 249 patients with ACLF, respectively.
Leukocyte count and plasma C-reactive protein level were measured in 759 and 550 patients without ACLF and in 176 and 142 patients with ACLF, respectively.
Leukocyte count and plasma C-reactive protein level were measured in 216 and 183 patients without ACLF and in 112 and 85 patients with ACLF, respectively.
Leukocyte count and plasma C-reactive protein level were measured in 158 and 130 patients without ACLF and in 82 and 64 patients with ACLF, respectively.
Adapted from Ref. 7. Data are means ± SD.